K991078

Substantially Equivalent

ACCUSIGN DOA8, DOA8 PANEL, THC/OPI/COC/AMP/BZO/BAR/TCA/PCP, BIOSIGN DOA8, THC/OPI/COC/AMP/BZO/BAR/TCA/PAP, STATUS DS DO8

Applicant: Princeton BioMeditech Corp.
Product code: DKE
Advisory panel: Clinical Toxicology
Date received: 1999-03-26
Decision date: 1999-04-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.